The high price of weight-loss drugs is frustrating for patients who can't access them, a doctor said.
Patients struggle to afford these drugs, leading to cycling, rationing, or using risky alternatives.
AdvertisementPharmaceutical companies are facing a new wave of criticism for the high price of groundbreaking weight-loss drugs.
The latest generation of these class of drugs, medications like Ozempic, Wegovy, Mounjaro, and Zepbound, are once-weekly injections.
The competitive pressure will also help drive prices lower as companies aim to attract consumers back to their brand with cheaper options for weight-loss drugs.
Persons:
—, Dr, Christopher McGowan, McGowan, that's, they've, Ted Kyle, Kyle
Organizations:
Service, Pharmaceutical, FDA